ClinConnect ClinConnect Logo
Search / Trial NCT04182269

Reliability and Validity of the Glittre Activities of Daily Living Test in Multiple Sclerosis Patients

Launched by HACETTEPE UNIVERSITY · Nov 27, 2019

Trial Information

Current as of August 15, 2025

Completed

Keywords

Multiple Sclerosis Glittre Adl Test Functional Capacity Assesment

ClinConnect Summary

Multiple Sclerosis (MS) is a chronic, inflammatory disease characterized by demyelination, myelin damage, axonal loss and gliosis in the Central Nervous System (CNS). MS symptoms vary according to the size of the lesion and its location in the CNS. Clinical symptoms are generally: spasticity, fatigue, muscle weakness, tremor, pain, sensory disturbances, bladder bowel problems, cognitive disorders, depression and sleep disorders. With the progression of the disease, the performance in daily living activities gradually decreases, affecting the quality of life negatively. Maintaining aerobic c...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Between 18-65 years
  • Relapsing Remitting Multiple Sclerosis (RRMS) type MS disease.
  • Extended Disability Status Scale (EDSS) score of maximum 4.5
  • No attacks during the last 3 months
  • The medication has not been changed in the last 6 months.
  • Getting more than 24 points from the Standardized Mini Mental Test.
  • Exclusion Criteria
  • Having had any musculoskeletal surgery.
  • Using a walking aid or orthosis.
  • Having a neurological disease other than MS.
  • Having orthopedic or rheumatological problems that will affect function.
  • Having a peripheral vestibular problem.
  • Having a cardiovascular and pulmonary disease.

About Hacettepe University

Hacettepe University is a leading research institution in Turkey, renowned for its commitment to advancing medical science and healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, the university supports a wide range of clinical trials aimed at improving patient outcomes and developing new therapeutic approaches. Hacettepe University is dedicated to maintaining the highest ethical standards and regulatory compliance in its research endeavors, fostering an environment that promotes scientific excellence and contributes to the global body of medical knowledge.

Locations

Ankara, , Turkey

Ankara, Sıhhiye/Ankara, Turkey

Patients applied

0 patients applied

Trial Officials

Nezire KÖSE, Prof.

Principal Investigator

Hacettepe University

Rana KARABUDAK, Prof.

Study Chair

Hacettepe University

Meryem A TUNCER, Prof.

Study Chair

Haceetepe University

Kadriye ARMUTLU, Prof.

Principal Investigator

Hacettepe University

Yeliz SALCI, Asts. Prof.

Principal Investigator

Hacettepe University

Jale KARAKAYA, Assoc. Prof.

Principal Investigator

Hacettepe University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials